Marshall Wace LLP raised its position in Silicon Laboratories Inc. (NASDAQ:SLAB - Free Report) by 1,041.8% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 73,095 shares of the semiconductor company's stock after buying an additional 66,693 shares during the quarter. Marshall Wace LLP owned about 0.23% of Silicon Laboratories worth $9,080,000 as of its most recent filing with the SEC.
Other institutional investors also recently bought and sold shares of the company. Raymond James Financial Inc. acquired a new position in Silicon Laboratories in the 4th quarter valued at $14,252,000. Arizona State Retirement System grew its stake in shares of Silicon Laboratories by 1.8% during the 4th quarter. Arizona State Retirement System now owns 9,360 shares of the semiconductor company's stock worth $1,163,000 after purchasing an additional 167 shares during the period. Franklin Resources Inc. grew its stake in shares of Silicon Laboratories by 1.9% during the 3rd quarter. Franklin Resources Inc. now owns 231,889 shares of the semiconductor company's stock worth $27,001,000 after purchasing an additional 4,278 shares during the period. Barclays PLC grew its stake in shares of Silicon Laboratories by 23.4% during the 3rd quarter. Barclays PLC now owns 70,568 shares of the semiconductor company's stock worth $8,157,000 after purchasing an additional 13,363 shares during the period. Finally, Arkadios Wealth Advisors acquired a new position in shares of Silicon Laboratories during the 4th quarter worth $237,000.
Insiders Place Their Bets
In other news, Director Navdeep S. Sooch sold 2,360 shares of the business's stock in a transaction on Wednesday, February 5th. The shares were sold at an average price of $149.00, for a total transaction of $351,640.00. Following the completion of the sale, the director now directly owns 400,567 shares of the company's stock, valued at $59,684,483. The trade was a 0.59 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director William G. Bock sold 1,000 shares of the business's stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $149.43, for a total transaction of $149,430.00. Following the sale, the director now directly owns 31,115 shares of the company's stock, valued at $4,649,514.45. This represents a 3.11 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by insiders.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently weighed in on SLAB shares. KeyCorp upped their price target on shares of Silicon Laboratories from $115.00 to $160.00 and gave the stock an "overweight" rating in a research note on Wednesday, January 22nd. Needham & Company LLC reaffirmed a "buy" rating and set a $150.00 price target on shares of Silicon Laboratories in a research note on Wednesday, March 12th. Stifel Nicolaus lowered their price target on shares of Silicon Laboratories from $145.00 to $120.00 and set a "buy" rating on the stock in a research note on Thursday, April 17th. Benchmark reiterated a "buy" rating and issued a $160.00 price objective on shares of Silicon Laboratories in a research report on Wednesday, March 12th. Finally, Barclays decreased their price objective on shares of Silicon Laboratories from $120.00 to $80.00 and set an "equal weight" rating on the stock in a research report on Tuesday, April 22nd. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $129.00.
Get Our Latest Report on Silicon Laboratories
Silicon Laboratories Price Performance
NASDAQ:SLAB traded down $0.14 on Monday, reaching $102.62. The stock had a trading volume of 201,591 shares, compared to its average volume of 326,323. The company has a market cap of $3.33 billion, a price-to-earnings ratio of -17.28 and a beta of 1.33. The firm's fifty day moving average is $115.59 and its two-hundred day moving average is $120.99. Silicon Laboratories Inc. has a 12-month low of $82.82 and a 12-month high of $160.00.
Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last released its earnings results on Tuesday, February 4th. The semiconductor company reported ($0.11) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.11). The company had revenue of $166.25 million for the quarter, compared to analyst estimates of $166.09 million. Silicon Laboratories had a negative net margin of 32.69% and a negative return on equity of 10.46%. The firm's quarterly revenue was up 91.4% on a year-over-year basis. During the same period in the prior year, the firm earned ($1.19) EPS. As a group, research analysts forecast that Silicon Laboratories Inc. will post -0.97 earnings per share for the current fiscal year.
Silicon Laboratories Profile
(
Free Report)
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Read More

Before you consider Silicon Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.
While Silicon Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report